Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy.

Cohen JV, Chiel L, Boghossian L, Jones M, Stopfer JE, Powers J, Rebbeck TR, Nathanson KL, Domchek SM. Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy. Fam Cancer. 2012 Mar; 11(1):69-75.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.